Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera

Viral Immunology

Volumn 19, Issue 4, 2006, Pages 623-629

  Chongsrisawat, Voranush ^a   Thawornsuk, Nutchanart ^a   Theamboonlers, Apiradee ^a   Louisirirotchanakul, Suda ^b   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; PROTEIN S; VIRUS DNA;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CHILD; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MALE; NUCLEOTIDE SEQUENCE; REVIEW; SERODIAGNOSIS; THAILAND; VIRUS MUTANT; VIRUS NEUTRALIZATION;

HEPATITIS B VIRUS;

EID: 33846053976     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.623     Document Type: Review

References (35)

1. Wai CT, and Fontana RJ: Clinical significance of hepatitis B virus genotypes, variants, and mutants. Clin Liver Dis 2004;8:321-352.
2. Norder H, Hammas B, Lofdahl S, Courouce AM, and Magnius LO: Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 1992;73:1201-1208.
3. Ohnuma H, Yoshikawa A, Mizoguchi H, and Okamoto H: Characterization of genotype H hepatitis B virus strain identified for the first time from a Japanese blood donor by nucleic acid amplification test. J Gen Virol 2005; 86:595-599.
4. Carman WF, Zanetti AR, Karayiannis P, et al.: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.
5. Kfoury Baz EM, Zheng J, Mazurak K, Van Le A, and Peterson DL: Characterization of a novel hepatitis B virus mutant: Demonstration of mutation-induced hepatitis B virus surface antigen group specific determinant conformation change and its application in diagnostic assays. Transfus Med 2001;11:355-362.
6. Moerman B, Moons V, Sommer H, Schmitt Y, and Stetter M: Evaluation of sensitivity for wild-type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 2004;50:159-162.
7. Coleman PF, Chen YC, and Mushahwar IK: Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999;59:19-24.
8. Ireland JH, O Donnell B, Basuni AA, et al.: Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000;31: 1176-1182.
9. Louisirirotchanakul S, Kanoksinsombat C, O'Charoen R, et al.: HBsAg diagnostic kits in the detection of HBV mutation within determinant. Viral Immunol 2006;19:108-114.
10. Ng KP, and Saw TL: Concurrence of hepatitis B surface antigen and antibody in acute and chronic hepatitis B cases. Med J Malaysia 1994;49:117-121.
11. Wang YM, Ng WC, Kang JY, et al.: Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrence presence of HBsAg and anti-HBs. Singapore Med J 1996;37:150-152.
12. Hayashi J, Noguchi A, Nakashima K, Morofuji M, and Kashiwagi S: Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan. Gastroenterol Jpn 1990;25:593-597.
13. Louisirirotchanakul S, Kanoksinsombat C, Theamboonlert A, Puthavatana P, Wasi C, and Poovorawan Y: Mutation of determinant of HBsAg with discordant HBsAg diagnostic kits. Viral Immunol 2004;17:440-444.
14. Theamboonlers A, Chongsrisawat V, Jantaradsamee P, and Poovorawan Y: Variants within the determinant of HBsAg in children and adolescents with and without hepatitis B vaccination as part: of Thailand expanded program on immunization (EPI). Tohoku J Exp Med 2001;193:197-205.
15. Payungporn S, Tangkijvanich P, Jantaradsamee P, Theamboonlers A, and Poovorawan Y: Simultaneous quantitation and genotyping of hepatitis B virus by real-time PCR and melting curve analysis. J Virol Methods 2004;120: 131-140.
16. Chongsrisawat V, Yoocharoen P, Theamboonlers A, et al.: Hepatitis B seroprevalence in Thailand: Twelve years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006;11:1496-502.
17. Weber B, Bayer A, Kirch P, Schluter V, Schlieper D, and Melchior W: Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol 1999;37:2639-2647.
18. Weber B: Genetic variability of the S gene of hepatitis B virus: Clinical and diagnostic impact. J Clin Virol 2005; 32:102-112.
19. Tabor E, Gerety RJ, Smallwood LA, and Barker LF: Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol 1977;118: 369-370.
20. Courouce-Pauty AM, Drouet J, and Kleinknecht D: Simultaneous occurrence in the same serum of hepatitis B surface antigen and antibody to hepatitis B surface antigen of different subtypes. J Infect Dis 1979;140:975-978.
21. Zaaijer HL, Lelie PN, Vandenbroucke-Grauls CM, and Koot M: Concurrence of hepatitis B surface antibodies and surface antigen: Implications for postvaccination control of health care workers. J Viral Hepat 2002;9:146-148.
22. Yamamoto K, Horikita M, Tsuda F, et al.: Naturally occurring escape mutants of hepatitis B with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994;68:2671-2676.
23. Shiels MT, Taswell HF, Czaja AJ, Nelson C, and Swenke P: Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology 1987;93:675-680.
24. Weinberger KM, Zoulek G, Bauer T, Bohm S, and Jilg W: A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol 1999;58:105-110.
25. Shinji T, Koide N, Hanafusa T, et al.: Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen. Hepatogastroenterology 1998;45:500-502.
26. Villeneuve JP: The natural history of chronic hepatitis B virus infection. J Clin Virol 2005;34(Suppl 1):S139-S142.
27. Allain JP: Occult hepatitis B virus infection. Transfus Clin Biol 2004;11:18-25.
28. Chemin I, and Trepo C: Clinical impact of occult HBV infections. J Clin Virol 2005;34(Suppl 1):S15-S21.
29. Hsu HY, Chang MH, Liaw SH, Ni YH, and Chen HL: Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999;30:1312-1317.
30. Noborg U, Gusdal A, Horal P, and Lindh M: Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 2000;32:249-252.
31. Shih LN, Sheu JC, Wang JT, et al.: Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J Med Virol 1990;32: 257-260.
32. Yotsuyanagi H, Yasuda K, Iino S, et al.: Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998;27:1377-1382.
33. Roth WK, Weber M, Petersen D, et al.: NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002;42:869-875.
34. Terada T, Moriyama M, Uchida T, and Arakawa Y: Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carriers who are negative for serum hepatitis B core antibody. Intervirology 2001;44:243-249.
35. Gotoh K, Mima S, Uchida T, et al.: Nucleotide sequence of hepatitis B virus isolated from subjects without serum antihepatitis B core antibody. J Med Virol 1995;46:201-206.